Effects of E-Cigarette Flavors on Adult E-Cigarette Users With Opioid Use Disorder
NCT07594717 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 70
Last updated 2026-05-22
Summary
This study examines the effects of e-cigarette (EC) flavors among adults with opioid use disorder (OUD) receiving buprenorphine treatment who currently use e-cigarettes. Participants will smell and rate 11 EC flavors based on appeal, sensory characteristics, and likelihood of future use. Researchers will examine how different flavor profiles influence the appeal and reinforcing effects of ECs in this population. The goal is to identify EC flavors that may enhance the acceptability of ECs as a potential harm-reduction strategy among adults with OUD receiving buprenorphine treatment.
Conditions
- Nicotine Use Disoder
- Opioid Use Disorder
Interventions
- DRUG
-
Tobacco flavor EC
Tobacco flavor EC
- DRUG
-
Sweet-cooling
Sweet-cooling EC flavor
- DRUG
-
Sweet non-cooling EC flavor
Sweet non-cooling flavor
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
collaborator NIH -
Prisma Health-Upstate
lead OTHER
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-11-12
- Primary Completion
- 2026-05-31
- Completion
- 2026-05-31
Countries
- United States
Study Locations
More Related Trials
-
Effects of Buprenorphine/Naloxone Administered in Different Ways For Treating Opioid Dependence
NCT00134914 ·Status: COMPLETED ·Phase: NA
-
Cannabidiol Use to Reduce Cravings in Individuals With Opioid Use Disorder on Buprenorphine
NCT04192370 ·Status: COMPLETED ·Phase: PHASE2
-
Buprenorphine as a Treatment in Opiate Dependent Pain Patients
NCT00552578 ·Status: TERMINATED ·Phase: PHASE4
-
Discontinuation From Chronic Opioid Therapy For Pain Using a Buprenorphine Taper
NCT02737826 ·Status: COMPLETED ·Phase: NA
-
Incentive-based Smoking Cessation for Methadone Patients
NCT00718835 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Buprenorphine on Mood in Adults With a Range of Depressive Symptomatology
NCT02659787 ·Status: COMPLETED ·Phase: NA
-
Ketamine for the Treatment of Opioid Use Disorder and Depression
NCT04177706 ·Status: COMPLETED ·Phase: PHASE2
-
CBT4CBT-Buprenorphine + Recovery Coach for Office-based Buprenorphine
NCT04824404 ·Status: COMPLETED ·Phase: NA
-
Oral Buprenorphine as a Novel Low-dose Induction Strategy for Opioid Use Disorder
NCT06086275 ·Status: COMPLETED ·Phase: PHASE1
-
A Brief Values Intervention to Support Veterans in Early Buprenorphine Treatment
NCT05189223 ·Status: RECRUITING ·Phase: NA
-
Cannabis and Opioid Use Disorder
NCT05729932 ·Status: RECRUITING ·Phase: PHASE1
-
Opioid Use Disorder Treatment Linkage at Sexual Health Clinics Using Buprenorphine
NCT04991974 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2/PHASE3
-
Safety and Health Intervention Project
NCT02152397 ·Status: COMPLETED ·Phase: NA
-
Temporal Discounting Delayed Outcomes on Opioid-Dependent Outpatients - 20
NCT00000238 ·Status: COMPLETED ·Phase: PHASE2
-
Buprenorphine Dose Alteration Study - 1
NCT00000219 ·Status: COMPLETED ·Phase: PHASE1
-
Improving Office Based Treatment of Opioid Use Disorder With Technology
NCT03586466 ·Status: UNKNOWN ·Phase: NA
-
Clinical Decision Support to Implement ED-initiated Buprenorphine for OUD
NCT03658642 ·Status: COMPLETED ·Phase: NA
-
Low-dose Versus a High-dose Sublingual Buprenorphine Induction
NCT05944952 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Optimizing Outcomes Using Suboxone for Opiate Dependence
NCT00591617 ·Status: COMPLETED ·Phase: NA
-
Better Experiences in Substance Treatment: A Brief Alcohol-focused Intervention Tailored for Patients in Opioid Agonist Treatment
NCT07342504 ·Status: RECRUITING ·Phase: NA
-
HMP for Addictions Study
NCT06063499 ·Status: WITHDRAWN ·Phase: NA
-
Effects of Dronabinol in Opioid Maintained Patients
NCT04025359 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Use of Transcranial Magnetic Stimulation to Reduce Craving for Individuals With Opioid Use Disorder Taking Buprenorphine
NCT03653169 ·Status: WITHDRAWN ·Phase: NA
-
Effects of Buprenorphine/Naloxone Dose on Experimental Stress Reactivity and Opioid Abstinence
NCT03015246 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Tolerability of Cannabidiol Among Persons With Opioid Use Disorder Receiving Methadone or Buprenorphine
NCT05076370 ·Status: COMPLETED ·Phase: EARLY_PHASE1